Capital Fund Management (CFM)
TTPH

Capital Fund Management (CFM)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Capital Fund Management (CFM)’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-860
Closed -$118K – 2057
2017
Q3 		$118K Buy
+860
New +$115K ﹤0.01% 1475

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Fund Management (CFM)'s TTPH Position: Q4 2017 in Review

Capital Fund Management (CFM) sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017, closing a stake of 860 shares — an estimated $118K sold.

Capital Fund Management (CFM) first reported a position in TTPH in Q3 2017 and held it in 1 quarter. The position peaked at $118K in Q3 2017. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • Capital Fund Management (CFM) reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 860 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $118K.
  • Capital Fund Management (CFM) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Tetraphase Pharmaceuticals, Inc. position peaked at $118K in Q3 2017.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2017, filed 9 Feb 2018.